Title: Serious liver disease in a patient receiving methotrexate and leflunomide
Abstract: Arthritis & RheumatismVolume 43, Issue 11 p. 2609-2611 Concise CommunicationFree to Read Serious liver disease in a patient receiving methotrexate and leflunomide Michael E. Weinblatt MD, Michael E. Weinblatt MD Brigham and Women's Hospital, Boston, MASearch for more papers by this authorJonathan A. Dixon MD, Jonathan A. Dixon MD Rheumatology Associates, Hartford, CTSearch for more papers by this authorKenneth R. Falchuk MD, Kenneth R. Falchuk MD Beth Israel Deaconess Hospital, Boston, MASearch for more papers by this author Michael E. Weinblatt MD, Michael E. Weinblatt MD Brigham and Women's Hospital, Boston, MASearch for more papers by this authorJonathan A. Dixon MD, Jonathan A. Dixon MD Rheumatology Associates, Hartford, CTSearch for more papers by this authorKenneth R. Falchuk MD, Kenneth R. Falchuk MD Beth Israel Deaconess Hospital, Boston, MASearch for more papers by this author First published: 26 March 2001 https://doi.org/10.1002/1529-0131(200011)43:11<2609::AID-ANR32>3.0.CO;2-RCitations: 34AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morell M, et al. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 1999; 42: 1322–8. 2 Kremer JM, Alarcón GS, Lightfoot RW Jr, Wilkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994; 37: 316–28. 3 Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542–50. 4 Erickson AR, Reddy V, Vogelgesang SA, West SG. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum 1995; 38: 1115–9. Citing Literature Volume43, Issue11November 2000Pages 2609-2611 ReferencesRelatedInformation